Brief: Generation Bio Q2 EPS USD -0.31 Vs. IBES Estimate USD -0.28
Aug 07 (Reuters) - Generation Bio Q2 operating expenses USD 27.4 million. * Q2 basic EPS USD -0.31 * Q2 operating income USD -23.309 million * Q2 net income USD -20.432 million vs. IBES estimate USD -16.8 million
Recent news on Generation Bio
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member